Abstract
Individuals with moodiness, mood problems, and ADHD symptoms regularly show up in mental health or medical care settings, and must be accurately diagnosed to receive appropriate treatment. An accurate assessment of such patients often requires a careful evaluation of current and past potential mood, ADHD, and other symptoms from the patient’s and others’ perspectives. Helpful information may include history from family, significant others, teachers, coworkers, and medical or mental health providers, as well as prior evaluations, transcripts and school reports, employment records, and even legal documents. Formal structured or semi-structured interviews are considered the “gold standard” for assessing such patients, but are usually limited to research settings. Clinicians can also provide proper diagnoses and treatment of such patient’s symptoms through careful clinical interviews and mental status exams, supplemented with well-validated general and more specific rating scales that screen for various mental health problems and impairment related to them. Systematic use of such rating scales also allows the clinician to monitor ongoing symptoms, identify adverse changes, and achieve better outcomes with treatment.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
- Mood
- Emotional dysregulation
- ADHD
- Comorbidity
- Informants
- Rating scales
- Questionnaires
- Clinical interview
- Structured interview
- Mental status exam
- Treatment monitoring
Introduction
Mood and affect problems and symptoms of inattention, hyperactivity, and impulsivity are common in society, and particularly in mental health and primary care settings. Such problems impair patients’ relationships with family and friends, their academic and occupational function, and ultimately the course of their lives. Careful and comprehensive assessment can lay the groundwork for effective treatments that can be life-changing. The list of differential diagnoses is long, and includes mood disorders, anxiety disorders, substance use disorders, personality disorders, and disruptive behavioral disorders, any of which can also have organic or substance-related etiologies. An effective initial interview will consider each of these groups of potential causes for the presenting symptoms, but may require multiple additional steps to gather more information. Sources of such information will include the patient and often other collateral informants , but may also include old medical, mental health, employment and academic evaluations, and sometimes behavioral comments on old report cards. Much of this information can be assimilated prior to the clinician’s evaluation.
Often the clinician must integrate incomplete, potentially inaccurate, and sometimes contradictory information from different informants , and carefully weigh such informants’ potential accuracy, biases, and motivations. Patients with ADHD, by definition, are inattentive, hyperactive or impulsive, and may give inaccurate answers, whether intentional or not. Patients or family members may underreport the patient’s symptoms due to denial, poor insight, skepticism about mental illnesses, discomfort with the patient being “labeled,” or simply to defy whichever party requested the evaluation without their blessing. In children or adolescents, such discordance may reflect parental conflicts with each other, with the patient, or with the school. Patients with ADHD often tend to overestimate their competence in various areas, a trait known as “positive illusory bias ” [1, 2]. On the other hand, patients or family members may overreport the patient’s symptoms when anxious or depressed [3], to seek academic or occupational accommodations or a medical excuse, or to obtain medications they hope will be therapeutic for the patient, or that they may divert or misuse. The late US president, Ronald Reagan, when asked about his confidence that his Russian counterparts would comply with a historical treaty intended to reduce both countries’ nuclear arsenals, stated simply that he would “trust, but verify.” Clinicians should use the same approach with information provided by patients and other informants , especially when their clinical observations and gut feelings raise doubts.
History of Present Illness, Past History, Family History, and Staging the Interview
For patients of all ages, proper psychiatric assessment will often require several stages [4,5,6]. The first stage will generally include brief introductions with the patient and other informants to review basic identifying information, chief complaints, goals for the evaluation, and further stages. At that time, the clinician can review aspects and limits of confidentiality. The next stages in the case of child or adolescent patients involve interviewing the child/adolescent and parent separately. This gives each party the chance to confidentially discuss their side of the story about the reported problems, as well as other potentially sensitive issues, and for the clinician to observe how reports, behaviors, and attitudes change when the other informant is no longer present. This also gives the clinician the chance to compare each party’s answers to similar questions. The time spent with each party will vary, depending on the chief complaints, each party’s willingness to participate in a separate interview, and the clinician’s opinion about the relative reliability of each party in reporting their clinical concerns [6].
As a general rule, the proportion of time the clinician spends with a child or adolescent patient will generally increase with the patient’s age, assuming he or she is cooperative and judged to be a good informant [4,5,6]. However, even brief interviews with younger children can provide useful observations about their activity level, mood and affect, developmental level, speech and language skills, and ability to handle a brief separation from their parent or other caregiver [4]. Clinicians should adjust their style and language level to the patient’s maturity, intelligence and language skills [4, 5]. In young patients, it is particularly important to “break the ice” by adopting a comfortable and reassuring demeanor and asking less probing questions first, perhaps about hobbies, activities, friendships, experiences in school, and relationships with family [4, 5]. Any suggested problems can then be followed up with questions about mood, anxiety, obsessive compulsive, psychotic, and behavioral symptoms, and how those impact such activities. The individual interview also provides the chance to ask about trauma exposure, sexual activity, drug/alcohol use, suicidal ideations and behaviors, and other risky behaviors or potential safety concerns. Reassuring patients that these are routine questions asked of all patients can make them more forthcoming in disclosing their problems and concerns. Above all, close observation of the patient’s mood, affect, and behaviors during the interview is critical. Feelings the patient evokes in the examiner (e.g., sadness, anxiousness, hopelessness, pity, irritation) often provide important clues about patients’ underlying mood and thoughts [4, 5].
A similar approach in interviewing adult patients can be equally helpful, assuming they have age-appropriate maturity, communication and cognitive skills. Finding the proper balance between developing an alliance with the patient, and maintaining proper boundaries and a neutral perspective can be especially important but tricky. In adult patients who are the persons of interest, they should be allowed greater say regarding what happens during the diagnostic process and the degree that other informants may participate. The clinician, however, can also set limits when necessary, especially since the diagnosis of ADHD requires such collateral information , and when the patient’s thoughts and behaviors represent potential safety concerns.
How patients present themselves in the interview can also be quite informative. Do they seem sincere and trustworthy? Are they appropriately dressed, with good hygiene, or seem disorganized or disheveled? Do they seem distracted, spacey, or forgetful? Do they show signs of hyperactivity such as fidgetiness, or impulsivity such as answering questions prematurely? Do they report cognitive and vegetative symptoms of depression or any signs and symptoms suggestive of mania or psychosis? What kind of feelings do they evoke in you as the clinician through their behaviors and interactions: sympathy, irritation, anxiety, skepticism, fear? Do they have appropriate feelings about their presenting complaints?
Time spent with the parents or other family members, either alone or with the patient, is essential in the case of child and adolescent assessments , and often helpful in the case of adult patients too. Parents and other family members will often be more reliable reporters regarding the patient’s ADHD and other externalizing behaviors, and other potentially sensitive issues about the patient’s substance use, and social, school, work, family, or legal problems. Parents often will be better able to provide past psychiatric, medical, family, and socio-developmental history as well as relevant stressors or trauma exposure that the patient has no awareness of, or has chosen to withhold [6]. The clinician may use separate time with only the parent of a child patient to share clinical impressions and propose next steps regarding assessment and treatment of the patient. This is often a good time to discuss making sure that the parent’s or other family members’ mental health needs are also being appropriately addressed. Such time with parents and other family members helps the clinician to anticipate potential problems the patient or parent could have in both accepting and complying with the clinician’s recommendations for treatment.
Additional information about the patient’s past psychiatric history from the patient or family can also be helpful, including past diagnoses, experiences with prior therapy or pharmacological treatments, suicide attempts or self-injury, hospitalizations and the indications for them. If considering pharmacotherapy, it is important to review any prior medications tried and the patient’s response to them. Careful review of past medical history and reports of any current somatic symptoms could suggest a tendency to overreport physical complaints that could be blamed as a medication side effect, or could suggest a potential medical problem that could interfere with treatment, or at least require a medical workup and medical clearance before starting pharmacotherapy.
Information about the family history , from either the patient or parent, is also useful in understanding the patient’s current mental health issues and the environmental context in which they are occurring. Identifying past mental health issues in other family members can help to identify genetic risks for mood, ADHD, substance use, and autism spectrum disorders, as well as for suicidal behaviors. Information about family members’ responses to pharmacological treatments can be helpful in anticipating the patient’s responses to the same or similar medications. A family member at home with an active substance use problem could increase the patient’s risk of environmental adversities and trauma exposure, and is a relative contraindication to prescribing controlled substances like stimulants to the patient.
The Physical and Mental Status Examination
Obtaining vital signs, including blood pressure, pulse, weight, and height, is recommended as a routine part of psychiatric care, especially when considering a trial of a stimulant medication or other ADHD medication. If considering a trial of an atypical neuroleptic, baseline tests, such as an Abnormal Involuntary Movements Exam and measurement of waist circumference, as well as ordering a fasting blood glucose and lipids are recommended [7]. Observations of either motor or vocal tics are important to document and potentially discuss with the patient and family. When considering pharmacological treatment for ADHD, especially with a stimulant, a complete baseline physical exam is recommended , since hypertension, tachycardia, and structural or other heart problems are potential contraindications to such a trial [8, 9].
Structured Interviews and Rating Scales
As summarized in Table 2.1, there are several well-validated structured or semi-structured interviews to help clinicians’ reach more accurate diagnoses in patients of all ages. Though such interviews are considered the gold standard for mental health assessment, they are often time-consuming, impractical in clinical settings, and require training to be used validly.
Instead, the current standard of care for patients of all ages is a careful diagnostic interview, supplemented with collateral information from validated rating scales, screening for various diagnoses that could explain patients’ presenting complaints, or may require additional attention. Table 2.2 lists multiple different rating scales , along with relevant references. Using additional time during the interview to gather more information about symptoms reported on the questionnaires can be especially helpful. Reports by interview or rating scales about trauma exposure and other recent or ongoing stressors are especially important because they suggest contributing factors that could be targeted and mitigated with psychosocial interventions.
Neuropsychological, Continuous Performance, and Electroencephalogram (EEG) Tests
Although neuropsychological testing has been suggested to be an important potential component of the workup for ADHD in patients of all ages [10], such testing is often time-consuming and expensive, and not designed specifically to diagnose ADHD at any age according to both the American Academy of Pediatrics [9] and the American Academy of Child and Adolescent Psychiatry [8]. However, neuropsychological testing can be helpful in situations in which an underlying learning disorder or developmental language disorder is suspected, or when accommodations at school or in taking standardized tests are being considered. If possible, this could be done through the school’s special education team as it can be quite expensive and insurance may not cover it.
Multiple continuous performance tests have been available for years [11, 12], and are sometimes used in the assessment of potential individuals with ADHD of all ages. A recent literature review of the available options suggested they often have shown problems with retest reliability and in discriminating patients with and without ADHD, due to unacceptably high false positive and false negative tests, especially in the presence of comorbid psychiatric disorders or other brain problems [13]. Continuous performance tests are not a substitute for a good clinical interview. However, they have been treatment-sensitive in pharmacological trials of ADHD medications [14]. Table 2.2 has additional information about these too.
A test involving EEGs (known as NEBA) has recently been validated, and approved by the Food and Drug Administration, as a supplemental test for ADHD in children and adolescents [15]. The NEBA test involves an approximately 25 min EEG in which the patient’s ratio of theta to beta waves is determined. This ratio has been demonstrated to be a biomarker of ADHD [16], and may be useful in equivocal cases. See Table 2.2 for more information.
Summary and Next Steps
A careful psychiatric assessment is the cornerstone for diagnosing and effectively treating ADHD and the many disorders of moodiness associated with it. This requires a carefully staged interview of the patient and other key informants about the patient’s recent past history of mental health problems. Such interviews vary according to age, cooperativeness, and perceived ability of the patient and other informants to provide useful and accurate information about the reported problems. Rating scales about patients’ symptoms and associated impairment can help in screening, and guiding the interview, and may highlight and help to resolve contradictory reports. Once working diagnoses are determined, rating scales can be used subsequently to monitor changes in the patient’s symptoms with treatment, and to help guide further adjustments to the treatment. The next chapter will review potential organic causes of moodiness and ADHD symptoms. Later chapters will discuss assessment and treatment strategies for various potential causes of moodiness or mood problems in patients with ADHD.
References
Hoza B, Waschbusch DA, Pelham WE, Molina BS, Milich R. Attention-deficit/hyperactivity disordered and control boys’ responses to social success and failure. Child Dev. 2000;71(2):432–46.
Evangelista NM, Owens JS, Golden CM, Pelham WE. The positive illusory bias: do inflated self-perceptions in children with ADHD generalize to perceptions of others? J Abnorm Child Psychol. 2008;36(5):779–91.
Shea K, Daviss WB. Caregiver depressive symptoms predict discrepancies between caregiver, teacher, and youth ratings of psychopathology in adolescents with ADHD. Poster, 60th annual meeting of the American Academy of Child and Adolescent Psychiatry, 2013, Orlando, FL.
Kestenbaum CJ. The clinical interview of the child. In: Dulcan MK, Wiener JM, editors. Essentials of child and adolescent psychiatry. Arlington: American Psychiatric Publishing; 2006. p. 39–48.
King RA, Schowalter JE. The clinical interview of the adolescent. In: Dulcan MK, Wiener JM, editors. Essentials of child and adolescent psychiatry. Arlington: American Psychiatric Publishing; 2006. p. 49–56.
Leventhal BL, Crotts ME. The parent interview essentials of child and adolescent psychiatry. Arlington: American Psychiatric Publishing; 2006. p. 57–66.
Correll CU, Penzner JB, Parikh UH, Mughal T, Javed T, Carbon M, et al. Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2006;15(1):177–206.
Pliszka S, AACAP Work Group. On quality issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.
American Academy of Pediatrics Subcommittee on ADHD. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22.
Pritchard AE, Nigro CA, Jacobson LA, Mahone EM. The role of neuropsychological assessment in the functional outcomes of children with ADHD. Neuropsychol Rev. 2012;22(1):54–68.
Conners CK. Conners’ Continuous Performance Test-II (CPT-II) computer program for windows technical guide and software manual. Toronto: Multi-Health Systems Inc.; 2000.
Greenberg LM. The Test of Variables of Attention (Version 8.0) [Computer software]. TOVA Company: Los Alamitos; 2011.
Gualtieri CT, Johnson LG. ADHD: is objective diagnosis possible? Psychiatry (Edgmont). 2005;2(11):44–53.
Losier BJ, McGrath PJ, Klein RM. Error patterns of the Continuous Performance Test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry. 1996;37(8):971–87.
Snyder SM, Rugino TA, Homig M, Stein MA. Integration of an EEG biomarker with a clinician’s ADHD evaluation. Brain Behav. 2015;5(4):e00330.
Snyder SM, Hall JR. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol. 2006;23(5):440–55.
Kaufman J, Birmaher B, Axelson D, Perepletchikova F, Brent D, Ryan N. K-SADS-PL DSM-5. Pittsburgh: Western Psychiatric Institute and Clinic; 2016.
Reich W, Welner Z, Herjanic B. Diagnostic Interview for Children and Adolescents (DICA-IV) Windows Version: Software Manual for Child/Adolescent and Parent Versions. Multi-Health Systems: North Tonawanda; 1997.
Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000;39(1):28–38.
Sheehan DV, Sheehan KH, Shytle RD, Janavs J, Bannon Y, Rogers JE, et al. Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). J Clin Psychiatry. 2010;71(3):313–26.
First MB, Williams JBW, Karg RS, Spitzer RL. Structured Clinical Interview for DSM-5 Disorders, Clinician Version (SCID-5-CV). Arlington: American Psychiatric Association; 2015.
First MB, Williams JBW, Benjamin LS, Spitzer RL. User’s guide for the SCID-5-PD (Structured Clinical Interview for DSM-5 Personality Disorder). Arlington: American Psychiatric Association; 2015.
Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004;13(2):93–121.
Wolraich ML, Feurer ID, Hannah JN, Baumgaertel A, Pinnock TY. Obtaining systematic teacher reports of disruptive behavior disorders utilizing DSM-IV. J Abnorm Child Psychol. 1998;26(2):141–52.
Wolraich ML, Lambert W, Doffing MA, Bickman L, Simmons T, Worley K. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol. 2003;28(8):559–68.
Conners CK. Conners comprehensive behavior rating scales manual. Multi-Health Systems: Toronto; 2008.
Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40(2):168–79.
Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–56.
Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Biederman J, et al. Validity of pilot Adult ADHD Self- Report Scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry. 2006;18(3):145–8.
Conners CK, Erhardt D, Sparrow E. CAARS: Conner’s Adult ADHD Rating Scales: Multi-Health Systems Incorporated (MHS); 1999.
Gallagher R, Blader J. The diagnosis and neuropsychological assessment of adult attention deficit/hyperactivity disorder. Scientific study and practical guidelines. Ann N Y Acad Sci. 2001;931:148–71.
Brown TE. Brown Attention Deficit Disorder Scales (BADDS). 1st ed. San Antonio: The Psychological Corporation; 1996.
Roth RM, Isquith PK, Gioia GA. BRIEF-A: Behavior Rating Inventory of Executive Function—Adult Version: professional manual. Lutz: Psychological Assessment Resources; 2005.
Isquith PK, Roth RM, Gioia GA. Behavior Rating Inventory of Executive Function—Adult Version (BRIEF-A) Interpretive Report. Lutz: Psychological Assessment Resources; 2006.
Edwards MC, Gardner ES, Chelonis JJ, Schulz EG, Flake RA, Diaz PF. Estimates of the validity and utility of the Conners’ Continuous Performance Test in the assessment of inattentive and/or hyperactive-impulsive behaviors in children. J Abnorm Child Psychol. 2007;35(3):393–404.
Epstein JN, Conners CK, Sitarenios G, Erhardt D. Continuous performance test results of adults with attention deficit hyperactivity disorder. Clin Neuropsychol. 1998;12:155.
Epstein JN, Erkanli A, Conners CK, Klaric J, Costello JE, Angold A. Relations between Continuous Performance Test performance measures and ADHD behaviors. J Abnorm Child Psychol. 2003;31(5):543–54.
Hall CL, Valentine AZ, Groom MJ, Walker GM, Sayal K, Daley D, et al. The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review. Eur Child Adolesc Psychiatry. 2016;25(7):677–99.
Achenbach TM, Rescorla LA. Manual for the ASEBA School-Age Forms and Profiles. Burlington: University of Vermont Research Center for Children, Youth, and Families; 2001.
Achenbach TM. Child Behavior Checklist and related instruments, vol. 637. Hillsdale: Lawrence Erlbaum Associates, Inc; 1994. p. 517–49.
Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997;38(5):581–6.
Bird HR, Shaffer D, Fisher P, Gould MS, Staghezza B, Chen JY, et al. The Columbia Impairment Scale (CIS): Pilot findings on a measure of global impairment for children and adolescents. Int J Methods Psychiatr Res. 1993;3(3):167–76.
Guy W. ECDEU assessment manual for psychopharmacology, revised. Rockville: U.S. Department of Health, Education and Welfare; 1976.
Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, et al. The Texas Children’s Medication Algorithm roject: report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part II: Tactics. J Am Acad Child Adolesc Psychiatry. 2000;39(7):920–7.
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
Johnson JG, Harris ES, Spitzer RL, Williams JB. The Patient Health Questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health. 2002;30(3):196–204.
Costello EJ, Angold A. Scales to assess child and adolescent depression: checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry. 1988;27(6):726–37.
Daviss WB, Birmaher B, Melhem NA, Axelson DA, Michaels SM, Brent DA. Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects. J Child Psychol Psychiatry. 2006;47(9):927–34.
Angold A, Costello EJ, Messer SC, Pickles A. Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. Int J Methods Psychiatr Res. 1995;5(4):237–49.
Poznanski EO, Cook SC, Carroll BJ. A depression rating scale for children. Pediatrics. 1979;64(4):442–50.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
Kovacs M. The Children’s Depression, Inventory (CDI). Psychopharmacol Bull. 1985;21(4):995–8.
Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
Eaton WW, Smith C, Ybarra M, Muntaner C, Tien A. Center for Epidemiologic Studies Depression Scale: review and revision (CESD and CESD-R). In: Tien A, Maruish ME, editors. The use of psychological testing for treatment planning and outcomes assessment: instruments for adults. 3rd ed. Mahwah: Lawrence Erlbaum Associates Publishers; 2004. p. 363–77.
Gracious BL, Youngstrom EA, Findling RL, Calabrese JR. Discriminative validity of a parent version of the Young Mania Rating Scale. J Am Acad Child Adolesc Psychiatry. 2002;41(11):1350–9.
Youngstrom EA, Frazier TW, Demeter C, Calabrese JR, Findling RL. Developing a 10-item mania scale from the Parent General Behavior Inventory for children and adolescents. J Clin Psychiatry. 2008;69(5):831–9.
Youngstrom EA, Cooperberg M, Findling RL, Calabrese JR, editors. Identifying the most sensitive outcome measure for pediatric bipolar disorder. Annual meeting of the American Academy of Child and Adolescent Psychiatry; October 2003, Miami Beach, FL.
Pavuluri MN, Henry DB, Devineni B, Carbray JA, Birmaher B. Child mania rating scale: development, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 2006;45(5):550–60.
Henry DB, Pavuluri MN, Youngstrom E, Birmaher B. Accuracy of brief and full forms of the Child Mania Rating Scale. J Clin Psychol. 2008;64(4):368–81.
Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35.
Wagner KD, Hirschfeld RM, Emslie GJ, Findling RL, Gracious BL, Reed ML. Validation of the Mood Disorder Questionnaire for bipolar disorders in adolescents. J Clin Psychiatry. 2006;67(5):827–30.
Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873–5.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
Hamilton M. Rating depressive patients. J Clin Psychiatry. 1980;41(12 Pt 2):21–4.
March JS, Parker JD, Sullivan K, Stallings P, Conners CK. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(4):554–65.
Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 1999;38(10):1230–6.
Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371–9.
Lovejoy MC, Rasmussen NH. The validity of vigilance tasks in differential diagnosis of children referred for attention and learning problems. J Abnorm Child Psychol. 1990;18(6):671–81.
Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. Children’s Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(6):844–52.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006–11.
Rapp AM, Bergman RL, Piacentini J, McGuire JF. Evidence-based assessment of obsessive–compulsive disorder. J Cent Nerv Syst Dis. 2016;8:13–29.
Bamber D, Tamplin A, Park RJ, Kyte ZA, Goodyer IM. Development of a Short Leyton Obsessional Inventory for children and adolescents. J Am Acad Child Adolesc Psychiatry. 2002;41(10):1246–52.
Cooper J. The Leyton Obsessional Inventory. Psychol Med. 1970;1(1):48–64.
Foa EB, Coles M, Huppert JD, Pasupuleti RV, Franklin ME, March J. Development and validation of a child version of the obsessive compulsive inventory. Behav Ther. 2010;41(1):121–32.
Jones AM, De Nadai AS, Arnold EB, McGuire JF, Lewin AB, Murphy TK, et al. Psychometric properties of the obsessive compulsive inventory: child version in children and adolescents with obsessive-compulsive disorder. Child Psychiatry Hum Dev. 2013;44(1):137–51.
Huppert JD, Walther MR, Hajcak G, Yadin E, Foa EB, Simpson HB, et al. The OCI-R: validation of the subscales in a clinical sample. J Anxiety Disord. 2007;21(3):394–406.
Weathers FW, Blake DD, Schnurr PP, Kaloupek DG, Marx BP, Keane TM. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). National Center for PTSD; 2013 [updated 2013]. www.ptsd.va.gov.
Pynoos RS, Weathers FW, Steinberg AM, Marx BP, Layne CM, Kaloupek DG, et al. Clinician-Administered PTSD Scale for DSM-5—Child/Adolescent Version. White River Junction: National Center of PTSD; 2015. https://www.ptsd.va.gov/professional/assessment/child/caps-ca.asp.
Daviss WB, Diler RS. Suicidal behaviors in adolescents with ADHD: associations with depressive and other comorbidity, parent-child conflict, trauma exposure, and impairment. J Atten Disord. 2014;18(8):680–90.
Daviss WB, Diler RS, Birmaher B. Associations of lifetime depression with trauma exposure, other environmental adversities, and impairment in adolescents with ADHD. J Abnorm Child Psychol. 2009;37(6):857–71.
Weathers FW, Blake DD, Schnurr PP, Kaloupek DG, Marx BP, Keane TM. The Life Events Checklist for DSM-5 (LEC-5). National Center for PTSD; 2013. www.ptsd.va.gov.
Steinberg AM, Brymer MJ, Kim S, Briggs EC, Ippen CG, Ostrowski SA, et al. Psychometric properties of the UCLA PTSD reaction index: Part I. J Trauma Stress. 2013;26(1):1–9.
Briere J. Trauma Symptom Checklist for Young Children (TSCYC): professional manual. Odessa: Psychological Assessment Resources, Inc.; 2005.
Foa EB, Johnson KM, Feeny NC, Treadwell KR. The child PTSD Symptom Scale: a preliminary examination of its psychometric properties. J Clin Child Psychol. 2001;30(3):376–84.
Scheeringa MS, Haslett N. The reliability and criterion validity of the Diagnostic Infant and Preschool Assessment: a new diagnostic instrument for young children. Child Psychiatry Hum Dev. 2010;41(3):299–312.
Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). National Center for PTSD; 2013. www.ptsd.va.gov.
Robins DL, Fein DM, Barton BA. Modified checklist for autism in toddlers, revised with follow-up (M-CHAT-R/F): Self-published; 2009 [updated 2009]. https://m-chat.org/_references/mchatDOTorg.pdf.
Constantino JN, Gruber CP. Social Responsiveness Scale. 2nd ed. Los Angeles: Western Psychological Services; 2012.
Gilliam JE. Gilliam Autism Rating Scale. 3rd ed. PRO-ED: Austin; 2014.
Lord C, Rutter M, DiLavore PC, Risi S, Gotham K, Bishop S. Autism diagnostic observation schedule. 2nd ed. Torrance: Western Psychological Services; 2012.
Knight JR, Shrier LA, Bravender TD, Farrell M, Vander Bilt J, Shaffer HJ. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999;153(6):591–6.
Bradley KA, Bush KR, Epler AJ, Dobie DJ, Davis TM, Sporleder JL, et al. Two brief alcohol-screening tests from the Alcohol Use Disorders Identification Test (AUDIT): validation in a female veterans affairs patient population. Arch Intern Med. 2003;163(7):821–9.
Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252(14):1905–7.
Larance B, Bruno R, Lintzeris N, Degenhardt L, Black E, Brown A, et al. Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: the Opioid-Related Behaviours In Treatment (ORBIT) scale. Drug Alcohol Depend. 2016;159:42–52.
Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abus Treat. 2007;32(2):189–98.
Selzer ML, Vinokur A, van Rooijen L. A self-administered Short Michigan Alcoholism Screening Test (SMAST). J Stud Alcohol. 1975;36(1):117–26.
Marchant BK, Reimherr FW, Robison D, Robison RJ, Wender PH. Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale. Psychol Assess. 2013;25(3):942–50.
Wender PH. Attention-deficit hyperactivity disorder in adults. New York: Oxford University Press; 1995.
Reimherr FW, Marchant BK, Strong RE, Hedges DW, Adler L, Spencer TJ, et al. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry. 2005;58(2):125–31.
Rosler M, Retz W, Fischer R, Ose C, Alm B, Deckert J, et al. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry. 2010;11(5):709–18.
Barkley RA, Murphy KR. Deficient emotional self-regulation in adults with ADHD: the relative contributions of emotional impulsiveness and ADHD symptoms to adaptive impairments in major life activities. J ADHD Relat Disord. 2010;1(4):5–28.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Daviss, W.B., Bond, J. (2018). Assessment Strategies for Moody ADHD in Children, Adolescents, and Adults. In: Daviss, W. (eds) Moodiness in ADHD. Springer, Cham. https://doi.org/10.1007/978-3-319-64251-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-64251-2_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-64250-5
Online ISBN: 978-3-319-64251-2
eBook Packages: MedicineMedicine (R0)